Skip to main content

Overview

Dr. Nikolaos (Nicolas) A. Karakatsanis is performing basic, translational and clinical research to enhance the diagnostic, prognostic and theranostic value of Positron Emission Tomography (PET) imaging for cardiovascular, oncologic and neurologic diseases. His main research focus has been the development and validation of clinically feasible and quantitative PET/CT and PET/MR imaging methodologies, such as:

  • - novel and clinically adoptable whole-body dynamic PET acquisition protocols
  • - multi-parametric, dynamic and dual-tracer PET/MR imaging methods with a focus on translational imaging of cardiovascular diseases molecular activity
  • - whole-body PET tracers kinetic modeling analysis coupled with robust kinetic parameter estimation techniques at the image voxel level
  • - advanced 4D parametric PET/CT and PET/MR image reconstruction for enhanced molecular imaging quantification
  • - axially sparse PET detector geometries, acquisitions and reconstruction algorithms for cost-effective short and long (total-body) axial FOV PET imaging in the clinic,
  • - data-driven respiratory and cardiac motion estimation and correction techniques within and after PET image reconstruction
  • - synergistic PET/MR image reconstruction for partial volume error (PVE) correction
  • - evaluation of Time-of-Flight (TOF), Continuous Bed Motion (CBM) and Resolution Modeling (PSF) technologies clinical benefit in specific PET/CT & PET/MR protocols
  • - NECR-based PET dosage optimization

Highlights

  1. 1
    Physics in medicine and biology · 2022
    PMID: 35472757DOIFirst author23 citations
  2. 2
    Radiology. Imaging cancer · 2022
    PMID: 35275019PMCID: PMC8965533DOISenior author27 citations
  3. 3
    The British journal of radiology · 2026
    PMID: 41830147DOIeCommonsFirst and senior author6 citations

Publications

90 publications

Funding

4 grants

Active

3 grants
  • Co-I
    Brain fluid clearance and misfolded protein dynamics following traumatic brain injury
    National Institute on Aging · 2023–2029
    R01AG077576-01A1
  • Co-I
    Ultra-High Performance Brain-dedicated PET scanner for Neurology and Neuro-oncology imaging
    National Cancer Institute · 2023–2028
    R01CA275942-01A1
  • Co-I
    Somatostatin Receptor 2 Expression in Pituitary Neuroendocrine Tumors as a Basis for PET/MRI guided Subtype Stratification and Radiotherapy Planning
    National Cancer Institute · 2025–2027
    R21CA289111-01A1
Completed grants (1)
  • Sub-PI
    Dual-Tracer Dual-Bed Hybrid PET/MR Imaging to Study Atherosclerosis Pre and Post Sleep Apnea Treatment
    National Heart, Lung, and Blood Institute · 2017–2019 · via Mount Sinai School of Medicine
    R03HL140273-02

External relationships

Other

Positroptics LLC